Literature DB >> 5789158

Endocrine function of the thymus affecting neuromuscular transmission.

G Goldstein, W W Hofmann.   

Abstract

Mesh:

Year:  1969        PMID: 5789158      PMCID: PMC1578935     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  22 in total

1.  Does myasthenic serum bind to the neuromuscular junction?

Authors:  D E McFarlin; W K Engel; A J Strauss
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

2.  Experimental autoimmune thymitis. An animal model of human myasthenia gravis.

Authors:  G Goldstein; S Whittingham
Journal:  Lancet       Date:  1966-08-06       Impact factor: 79.321

3.  Neuromuscular transmission in vivo and the actions of decamethonium: a micro-electrode study.

Authors:  D V Roberts; S Thesleff
Journal:  Acta Anaesthesiol Scand       Date:  1965       Impact factor: 2.105

Review 4.  Current concepts of the immunological function of the thymus.

Authors:  J F Miller; D Osoba
Journal:  Physiol Rev       Date:  1967-07       Impact factor: 37.312

5.  Histological and serological features of experimental autoimmune thymitis in guinea-pigs.

Authors:  G Goldstein; S Whittingham
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

6.  Restoration of immunologic reactivity of thymectomized mice by calf thymus extracts.

Authors:  N Trainin; M Linker-Israeli
Journal:  Cancer Res       Date:  1967-02       Impact factor: 12.701

7.  Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin).

Authors:  A L Goldstein; F D Slater; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1966-09       Impact factor: 11.205

8.  Thymic germinal centres in myasthenia gravis: a correlative study.

Authors:  G Goldstein
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

9.  The thymus and neuromuscular function. A substance in thymus which causes myositis and myasthenic neuromuscular block in guineapigs.

Authors:  G Goldstein
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

10.  Thymitis and myasthenia gravis.

Authors:  G Goldstein
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

View more
  19 in total

Review 1.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

2.  Three distinct human thymopoietins are derived from alternatively spliced mRNAs.

Authors:  C A Harris; P J Andryuk; S Cline; H K Chan; A Natarajan; J J Siekierka; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  Thymus hormones.

Authors: 
Journal:  Br Med J       Date:  1977-06-18

4.  Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus.

Authors:  R S Basch; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

5.  Experimental myasthenia gravis, myositis and myocarditis in guinea-pigs immunized with subcellular fractions of calf thymus or calf skeletal muscle in Freund's complete adjuvant.

Authors:  J R Kalden; W G Williamson; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

Review 6.  Progress in myasthenia gravis.

Authors:  C W Havard
Journal:  Br Med J       Date:  1973-08-25

7.  The effect of thymectomy, hemi-thymectomy and sham thymectomy on experimental myasthenia gravis in guinea-pigs.

Authors:  J R Kalden; W G Williamson; W J Irvine
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

8.  Editorial: Thymic hormones.

Authors: 
Journal:  Br Med J       Date:  1974-07-13

9.  Experimental myasthenia in mice. The role of the thymus and lymphoid cells.

Authors:  S Kawanami; R Mori
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

10.  Immunological studies in patients with juvenile-onset myasthenia gravis and in their relatives.

Authors:  S Bundey; D Doniach; J F Soothill
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.